Advertisement
Advertisement

IXHL

IXHL logo

Incannex Healthcare Limited - ADR

4.58
USD
Sponsored
-0.22
-4.58%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

4.55

-0.03
-0.74%

IXHL Earnings Reports

Positive Surprise Ratio

IXHL beat 3 of 6 last estimates.

50%

Next Report

In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.94
Implied change from Q2 26 (Revenue/ EPS)
--
/
+56.67%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-99.61%

Incannex Healthcare Limited - ADR earnings per share and revenue

On Feb 13, 2026, IXHL reported earnings of -0.60 USD per share (EPS) for Q2 26, beating the estimate of -0.94 USD, resulting in a 36.50% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.94 USD, with revenue projected to reach -- USD, implying an increase of 56.67% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Quoin Pharmaceuticals, Ltd. - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.96
Actual
-$1.77
Surprise
+9.93%
logo
ZOETIS INC.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.63
Actual
$1.53
Surprise
-6.19%
logo
Stevanato Group S.p.A.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.10
Actual
$0.11
Surprise
+5.45%
logo
Crinetics Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.26
Actual
-$1.23
Surprise
+2.51%
logo
NewAmsterdam Pharma Company N.V. Ordinary Shares
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.40
Surprise
+20.32%
logo
Collegium Pharmaceutical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$1.62
Actual
$1.76
Surprise
+8.43%
logo
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+296.08%
logo
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
May 07, 2026 For Q1 26
Estimate
$0.24
Actual
$0.24
Surprise
-1.96%
logo
SIGA Technologies Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-
Actual
-$0.05
Surprise
-
logo
Profound Medical Corp. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+25.75%
FAQ
For Q2 2026, Incannex Healthcare Limited - ADR reported EPS of -$0.60, beating estimates by 36.5%, and revenue of --, 0% as expectations.
The stock price moved up 0.04%, changed from $0.27 before the earnings release to $0.27 the day after.
The next earning report is scheduled for May 13, 2026.
Based on 3 analysts, Incannex Healthcare Limited - ADR is expected to report EPS of -$0.94 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement